ConductScience.org, home
Journal index
API referenceFor AI assistants

Journal · 101676423

Signal transduction and targeted therapy

2 sourcesjournal-index-2026-11-06-0.2.0

Download JSON
Cite this record

ConductScience Library. Signal transduction and targeted therapy. Journal index, record 101676423. Release journal-index-2026-11-06-0.2.0, 6 Nov 2026. https://conductscience.org/library/journal-index/101676423

On this page

Journal

Counted by ScienceGraph from its copy of PubMed, by the NLM ID each paper's record states: papers from 1959 on, and no preprints, since until the copy is rebuilt from NLM's own files it holds few of PubMed's papers from before 1959 and about half its preprints.

Title
Signal transduction and targeted therapy
NLM Catalog
NLM ID
101676423
NLM Catalog
Abbreviation
Signal Transduct Target Ther
NLM Catalog
ISO abbreviation
Signal Transduct Target Ther
NLM Catalog
ISSN, print
2095-9907
NLM Catalog
ISSN, online
2059-3635
NLM Catalog
Named by
NLM's journal list
NLM Catalog
Papers since 1959
3,053
PubMed
Years
2016 to 2026
PubMed
Papers from 2021 to 2025
2,109
PubMed
Retracted papers
2
PubMed
Retraction notices
2
PubMed
Errata
82
PubMed
Expressions of concern
0
PubMed
Reviews
653
PubMed
Trials, by publication type
193
PubMed
With a copy in PMC
3,050
PubMed
With NIH grants
225
PubMed
With a ClinicalTrials.gov number
105
PubMed

Years11

Each paper counts in the year of its issue, as its record states. PubMed's search for a year also finds papers that appeared online that year, so its count can be higher. A part year is our copy's own year or later.

YearPapersWith a copy in PMCRetractedWith NIH grantsWith a ClinicalTrials.gov numberSource
2026, part year48848504517PubMed
202542842803339PubMed
202437137101427PubMed
202346746712312PubMed
20224024020154PubMed
20214414410314PubMed
20202992990281PubMed
20196464160PubMed
20183333060PubMed
201738380120PubMed

1 to 10 of 11

See all 11 years

Publication types28

NLM's publication types, as each record states them. A paper can have several.

TypePapersSource
Journal Article2,520PubMed
Research Support, Non-U.S. Gov't2,113PubMed
Review646PubMed
Letter441PubMed
Comment299PubMed
Research Support, N.I.H., Extramural147PubMed
Clinical Trial, Phase II102PubMed
Multicenter Study95PubMed
Published Erratum82PubMed
Randomized Controlled Trial73PubMed

1 to 10 of 28

See all 28 publication types

Retracted papers2

Papers whose PubMed record is typed Retracted Publication, with the notice PubMed links.

PMIDTitleYearRetraction noticeSource
37443111BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.202341484065PubMed
31839998Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway.201937147281PubMed

Newest papers20

The twenty newest papers in our copy of PubMed, by year and then PMID.

PMIDTitleYearSource
42988817Antibody-drug conjugates: unpacking toxicity profiles and optimized designs for enhanced safety and antitumor efficacy.2026PubMed
42988804Neutralization and protective effectiveness of three XBB vaccines in older adults 12 months after booster.2026PubMed
42982795Tumor vessel sabotage: CD4⁺ T cells enlist macrophages.2026PubMed
42977741An actionable GPCR restores phosphoinositide homeostasis and kidney function in Lowe syndrome.2026PubMed
42977736Epilepsy: epidemiology, risk factors, classification, pathophysiology, clinical features, diagnosis and management.2026PubMed
42971953Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial.2026PubMed
42967934Autoimmune-shared immune states converge in a CXCL12-CXCR4 fibroblast-immune niche in chronic antibody-mediated rejection.2026PubMed
42967914Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS).2026PubMed
42967906Complement deposition in the bone marrow of patients with myelodysplastic neoplasms.2026PubMed
42966824Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC.2026PubMed
42957669Primate embryoids: an in vitro model leading from a totipotency-like phase to early organogenesis.2026PubMed
42957652Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential.2026PubMed
42957648Aromaticity at spike position 456 affects functional immunogenicity of SARS-CoV-2 Omicron variant receptor-binding domain.2026PubMed
42951899Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency.2026PubMed
42951886Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases.2026PubMed
42946722TNF-induced lethality occurs independently of NLRP3 inflammasome signaling.2026PubMed
42946698Ginsenoside Rb1 alleviates uterine aging via AMPK-mediated mTOR inactivation.2026PubMed
42934236HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease.2026PubMed
42934234The AMPK signaling pathway in cell metabolism and human diseases.2026PubMed
42928347Encapsulated mitochondrial transplantation: Advancing organelle therapeutics.2026PubMed

Data dates

The date of each source this release read.

Our copy of PubMed
2026-11-06
NLM's journal list
2026-11-01

Sources 2

  • NLM's journal listNLM's terms
  • PubMedNLM's terms
Each source's terms
  • NLM's journal listNLM's
  • PubMedNLM's terms

For software

Read this journal from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/journal-index/v1/101676423

GET https://conductscience.org/api/journal-index/v1/101676423/types?page=2

API referenceFor AI assistants